"10.1371_journal.pone.0112294","plos one","2014-11-13T00:00:00Z","Joan Puig-Barberà; Juan García-de-Lomas; Javier Díez-Domingo; Alberto Arnedo-Pena; Montserrat Ruiz-García; Ramón Limón-Ramírez; Silvia Pérez-Vilar; José Luis Micó-Esparza; Miguel Tortajada-Girbés; Concha Carratalá-Munuera; Rosa Larrea-González; Juan Manuel Beltrán-Garrido; Maria del Carmen Otero-Reigada; Joan Mollar-Maseres; Patricia Correcher-Medina; Germán Schwarz-Chavarri; Vicente Gil-Guillén; for the Valencia Hospital Network for the Study of Influenza and Respiratory Virus Disease","Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain; Centro de Salud Pública de Castellón, Castellón, Spain; Instituto Valenciano de Microbiología, Valencia, Spain; Hospital de la Plana, Vila-real, Spain; Hospital Aranau de Vilanova, Valencia, Spain; Hospital Doctor Peset, Valencia, Spain; Hospital San Juan, Alicante, Spain; Cátedra de Medicina de Familia, Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan, Alicante, Spain; Hospital General de Castellón, Castellón, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; Hospital Lluis Alcanyis, Xativa, Spain, 12 Centro de Salud San Blas, Alicante, Spain, 13 Hospital de Elda, Elda, Spain; Centro de Salud San Blas, Alicante, Spain; Hospital de Elda, Elda, Spain","Conceived and designed the experiments: JPB. Analyzed the data: JPB AAP. Contributed reagents/materials/analysis tools: JGL. Wrote the paper: JPB JDD AAP JGL. Conception and design: MRG RLR SPV JLME MTG CCM RLG JMBG MCOR JMM PCM GSC VGG. Acquisition of data: MRG RLR SPV JLME MTG CCM RLG JMBG MCOR JMM PCM GSC VGG. Interpretation of data: MRG RLR SPV JLME MTG CCM RLG JMBG MCOR JMM PCM GSC VGG. Reviewed article or revised it critically for important intellectual content: MRG RLR SPV JLME MTG CCM RLG JMBG MCOR JMM PCM GSC VGG.","The authors have read the journal's policy and have the following conflicts: JPB and JDD work in FISABIO's Vaccines Research Area; FISABIO has received funding for GSK, Novartis, Pfizer, SanofiPasteur, Sanofi-Pasteur MSD for conducting epidemiological studies on infectious disease epidemiology, vaccine effectiveness, pharmacoeconomics, and safety studies. The Vaccines Research Area is and has been involved in various randomized clinical trials with GSK, Novartis, Pfizer and MSD vaccines. This specific study was funded by contracts between FISABIO-Salud Publica (former CSISP) and Sanofi-Pasteur and FISABIO-Salud Pública (former CSISP)and Sanofi-Pasteur MSD. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","11","Joan Puig-Barberà","JPB",18,TRUE,1,NA,2,4,TRUE,TRUE,TRUE,1,"18",TRUE
